Hematopoietic cell transplantation in inborn errors of immunity Part I: severe combined immunodeficiency
Open Access
- 22 January 2025
- journal article
- Published by Journal of Bone Marrow Transplantation and Cellular Therapy in JOURNAL OF BONE MARROW TRANSPLANTATION AND CELLULAR THERAPY
- Vol. 6 (1)
Abstract
Severe Combined Immunodeficiencies (SCID) are rare diseases characterized by a blockage in T-lymphocyte development. Hematopoietic Cell Transplantation (HCT) is the primary curative therapy, with the highest survival rates correlated to early diagnosis and the absence of active infections at transplant. The gold standard is a matched related sibling donor (MSD), but alternative donors like haploidentical family donors are increasingly used. Conditioning regimens vary, with reduced intensity busulfan and fludarabine often indicated. Early diagnosis via newborn screening and referral to experienced HCT centers are crucial for improving outcomes. Long-term follow-up is essential, as the cumulative incidence of late effects, such as neurologic and neurodevelopmental issues, increases over time.Keywords
This publication has 16 references indexed in Scilit:
- Posttransplantation late complications increase over time for patients with SCID: A Primary Immune Deficiency Treatment Consortium (PIDTC) landmark studyJournal of Allergy and Clinical Immunology, 2023
- Impact of Graft Function on Health Status and Quality of Life in Very Long-Term Survivors Who Received an HSCT for Inborn Errors of Immunity, a Prospective Study of the CEREDIHTransplantation and Cellular Therapy, 2023
- Late-onset enteric virus infection associated with hepatitis (EVAH) in transplanted SCID patientsJournal of Allergy and Clinical Immunology, 2023
- The diagnosis of severe combined immunodeficiency (SCID): The Primary Immune Deficiency Treatment Consortium (PIDTC) 2022 DefinitionsJournal of Allergy and Clinical Immunology, 2022
- Hematopoietic cell transplantation in severe combined immunodeficiency: The SCETIDE 2006-2014 European cohortJournal of Allergy and Clinical Immunology, 2022
- Long-Term Clinical Outcomes of Severe Combined Immunodeficiency Patients Given Nonablative Marrow TransplantsThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- EBMT/ESID inborn errors working party guidelines for hematopoietic stem cell transplantation for inborn errors of immunityBone Marrow Transplantation, 2021
- Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and TreatmentJournal of Clinical Immunology, 2021
- Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC CentersJournal of Clinical Immunology, 2020
- Consensus approach for the management of severe combined immune deficiency caused by adenosine deaminase deficiencyJournal of Allergy and Clinical Immunology, 2019